HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
HealthVerity data strengthens regulatory submissions and clinical trials
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
Curated data in life sciences: the cornerstone of research readiness and precision
This is part three of a three-part series on the essential qualities of claims data for life...
Consistent data in life sciences: the key to reliable, reproducible, and actionable research
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
The best closed claims data for RWE and HEOR — HealthVerity taXonomy
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
Verified Data: The foundation of trust in real-world evidence
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where...
How to optimize real-world data with lab results for clinical trials & HEOR
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
What’s Broken in Audience Targeting - And How to Fix It
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Unlock open and closed claims data with taXOnomy: Claim better outreach
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...